Begin main content

Open Calls for Patient Input

This page lists Common Drug Review (CDR) drug applications received by CADTH and the deadlines for filing patient group input for each drug. For more information about how to provide input, please visit the CDR Patient Input page

Izba (travoprost ophthalmic solution)

Indications: open-angle glaucoma

Call For Patient Input: January 31, 2017

Patient Input Closed: March 22, 2017

TBC (Baricitinib)

Indications: Rheumatoid arthritis

Call For Patient Input: January 30, 2017

Patient Input Closed: March 21, 2017

Repatha (evolocumab)

Indications: Primary hyperlipidemia and mixed dyslipidemia

Call For Patient Input: January 20, 2017

Patient Input Closed: March 13, 2017